Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

pLX304 Luciferase-V5 blast Citations (3)

Originally described in: Tumor-Suppressor Inactivation of GDF11 Occurs by Precursor Sequestration in Triple-Negative Breast Cancer.
Bajikar SS, Wang CC, Borten MA, Pereira EJ, Atkins KA, Janes KA Dev Cell. 2017 Nov 20;43(4):418-435.e13. doi: 10.1016/j.devcel.2017.10.027.
PubMed Journal

Articles Citing pLX304 Luciferase-V5 blast

Articles
Tousled-like kinase 2 targets ASF1 histone chaperones through client mimicry. Simon B, Lou HJ, Huet-Calderwood C, Shi G, Boggon TJ, Turk BE, Calderwood DA. Nat Commun. 2022 Feb 8;13(1):749. doi: 10.1038/s41467-022-28427-0. PubMed
A bi-steric mTORC1-selective inhibitor overcomes drug resistance in breast cancer. Meng D, Zhao X, Yang YC, Navickas A, Helland C, Goodarzi H, Singh M, Bandyopadhyay S. Oncogene. 2023 Jul;42(28):2207-2217. doi: 10.1038/s41388-023-02737-z. Epub 2023 Jun 1. PubMed
Role of Nudt2 in Anchorage-Independent Growth and Cell Migration of Human Melanoma. Hidmi S, Nechushtan H, Razin E, Tshori S. Int J Mol Sci. 2023 Jun 22;24(13):10513. doi: 10.3390/ijms241310513. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.